SI

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

Wall Street analysts forecast SI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SI is 19.40 USD with a low forecast of 18.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Shoulder Innovations Inc revenue for the last quarter amounts to 11.76M USD, increased 57.71 % YoY.

Shoulder Innovations Inc. EPS for the last quarter amounts to -0.64 USD, increased 220.00 % YoY.

Shoulder Innovations Inc (SI) has 0 emplpoyees as of December 16 2025.

Today SI has the market capitalization of 297.69M USD.